Literature DB >> 22783396

Cloning and sequencing of the light chain variable region from NS-1 myeloma.

Botao Ning1, Yongmin Tang, Hua Song, Shilong Yang, Hongqiang Shen.   

Abstract

The aim of this study was to clone the gene encoding the light chain variable region (V(L)) of the murine myeloma cell line P3/NS1/1-Ag4-1 (NS-1). Total RNA was prepared from the NS-1 cell line and its fusion hybridoma cell line 2F9. The V(L) gene was amplified using reverse transcription PCR (RT-PCR) with family-specific primer pairs. The PCR products were cloned into the pGEM(®)-T easy vector, transfected into E. coli DH5α cells and the positive recombinants were identified and purified with EcoRI digestion and agarose gel electrophoresis. The sequence was identified using an automatic DNA sequencer and analyzed online using the IMGT/V-QUEST program (version 3.2.21). The PCR product that was amplified with the P9 and P14 primers was approximately 392 bp in size. Following digestion with EcoRI, the band of interest was also detected in positive recombinants using agarose gel electrophoresis. The sequences from the NS-1 and 2F9 cells were identical. The whole sequence was 387 bp long, encoding 128 amino acids (AA), including a 60 bp leader sequence. There was a TAA stop codon at 385-387 bp and only one cysteine was found, at 112AA/128AA. Analysis using IMGT/V-QUEST determined the cloned V- and J-segments as murine IG(κ)KV3-12*01 and IG(κ)KJ2*01, respectively. Accordingly, the NS-1 V(L) gene belongs to the Ig(κ) gene family V3 subgroup. The NS-1 V(L) gene was successfully cloned and it is a pseudo-Igκ chain gene in NS-1 cells. This study may aid the sequencing of genes encoding monoclonal antibodies produced by mouse hybridomas raised with NS-1 myeloma.

Entities:  

Year:  2012        PMID: 22783396      PMCID: PMC3389680          DOI: 10.3892/ol.2012.601

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Direct cDNA cloning of the rearranged immunoglobulin variable region.

Authors:  Y L Chiang; R Sheng-Dong; M A Brow; J W Larrick
Journal:  Biotechniques       Date:  1989-04       Impact factor: 1.993

3.  Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells.

Authors:  Yong-Min Tang; Bo-Tao Ning; Jiang Cao; Hong-Qiang Shen; Bai-Qin Qian
Journal:  Immunopharmacol Immunotoxicol       Date:  2007       Impact factor: 2.730

Review 4.  Hybridoma technologies for antibody production.

Authors:  Masahiro Tomita; Kanta Tsumoto
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

5.  Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA.

Authors:  N J Cowan; D S Secher; C Milstein
Journal:  J Mol Biol       Date:  1974-12-25       Impact factor: 5.469

6.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

Review 7.  Hybridomas: a new dimension in biological analyses.

Authors:  R H Kennett
Journal:  In Vitro       Date:  1981-12

Review 8.  Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.

Authors:  Leonard G Presta
Journal:  Adv Drug Deliv Rev       Date:  2006-05-23       Impact factor: 15.470

9.  Monoclonal antibodies as diagnostics; an appraisal.

Authors:  M Z Siddiqui
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

10.  Purification of monoclonal antibodies with light-chain heterogeneity produced by mouse hybridomas raised with NS-1 myelomas: application of hydrophobic interaction high-performance liquid chromatography.

Authors:  N Abe; K Inouye
Journal:  J Biochem Biophys Methods       Date:  1993-10
View more
  2 in total

1.  Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci.

Authors:  Ermioni Kalfopoulou; Diana Laverde; Karmela Miklic; Felipe Romero-Saavedra; Suzana Malic; Filippo Carboni; Roberto Adamo; Tihana Lenac Rovis; Stipan Jonjic; Johannes Huebner
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

2.  Golgin Subfamily A Member 5 Is Essential for Production of Extracellular Matrix Proteins during TGF-β1-Induced Periodontal Ligament-Fibroblastic Differentiation.

Authors:  Hyun-Jin Kim; Seong-Min Kim; Min-Jeong Choi; Young-Joo Jang
Journal:  Stem Cells Int       Date:  2022-07-16       Impact factor: 5.131

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.